Sectors
RNTX
Rein Therapeutics Inc.
0.75
1 x 0.79
1 x 0.79
bid
ask
-
0.01
1.59%
02:08 PM
timesize
| Ytd | -35.34% | |
| 1y | -46.04% |
0.75
day range
0.78
0.69
52 week range
2.18
| Open | 0.77 | Prev Close | 0.76 | Low | 0.75 | High | 0.78 | Mkt Cap | 64.70M |
| Vol | 419.28K | Avg Vol | 505.65K | EPS | -1.68 | P/E | N/A | Forward P/E | N/A |
| Beta | 1.39 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-18 | 50-d Avg | 0.86 | 200-d Avg | 1.17 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 6.08M | ||
| Research and Development Expense | 3.64M | ||
| Selling, General and Administrative Expense | 2.44M | ||
| Operating Income | -6.08M | ||
| Net Income | -6.37M | ||
| Net Income Common Stock | -6.37M | ||
| Net Income Common Stock (USD) | -6.37M | ||
| Consolidated Income | -6.37M | ||
| Earnings per Basic Share | -0.10 | ||
| Earnings per Basic Share (USD) | -0.10 | ||
| Earnings per Diluted Share | -0.10 | ||
| Earning Before Interest & Taxes (EBIT) | -6.37M | ||
| Earning Before Interest & Taxes (USD) | -6.37M | ||
| Weighted Average Shares | 67.08M | ||
| Weighted Average Shares Diluted | 67.08M | ||
| Balance Sheet | |||
| Cash and Equivalents | 8.54M | ||
| Cash and Equivalents (USD) | 8.54M | ||
| Investments | 35.09M | ||
| Investments Current | 32.10M | ||
| Investments Non-Current | 2.98M | ||
| Current Assets | 41.45M | ||
| Total Assets | 65.97M | ||
| Current Liabilities | 9.71M | ||
| Total Liabilities | 10.77M | ||
| Accumulated Retained Earnings (Deficit) | -413.48M | ||
| Accumulated Other Comprehensive Income | -69.00K | ||
| Shareholders Equity | 55.20M | ||
| Shareholders Equity (USD) | 55.20M | ||
| Assets Non-Current | 24.52M | ||
| Goodwill and Intangible Assets | 19.83M | ||
| Liabilities Non-Current | 1.06M | ||
| Trade and Non-Trade Payables | 4.47M | ||
| Tax Liabilities | 1.06M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 47.82M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 4.10M | ||
| Issuance (Purchase) of Equity Shares | 53.19M | ||
| Issuance (Repayment) of Debt Securities | -5.37M | ||
| Net Cash Flow from Operations | -8.64M | ||
| Effect of Exchange Rate Changes on Cash | -5.00K | ||
| Share Based Compensation | 164.00K | ||